Also found in: Dictionary.
TAPETTumor Amplified Protein Expression Therapy
References in periodicals archive ?
We believe that VION is undervalued at this time, given its products and pipeline, the unique TAPET technology, its partnering strategy (and proven ability to secure partnerships), and the potential market for its products.
Tapet said the assignment of a 10percent participating interest in and under SC50 was subject to the approval of the Department of Energy (DOE).
SC50 is expected to start commercial production in the summer of 2015, giving Tapet an immediate revenue stream.
Note to Editors: Promycin and TAPET are registered trademarks of Vion Pharmaceuticals Inc.
TAPET may represent a significant advance in the gene therapy of cancer which we believe overcomes many of the shortcomings of other gene therapy delivery systems.